An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol

Psychiatry Research

Volumn 81, Issue 3, 1998, Pages 333-339

  Zhang Wong, Jiahui ^a   Beiser, Morton ^a   Zipursky, Robert B ^b   Bean, Graham ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Plasma levels; Prolactin; Schizophrenia

Indexed keywords

HALOPERIDOL;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG METABOLISM; ETHNIC GROUP; FEMALE; GENDER; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; ANTIPSYCHOTIC AGENTS; ASIAN AMERICANS; CROSS-CULTURAL COMPARISON; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HALOPERIDOL; HUMANS; MALE; METABOLIC CLEARANCE RATE; PROLACTIN; SCHIZOPHRENIA; SEX FACTORS;

EID: 0032517870     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00114-0     Document Type: Article

References (24)

1. Abernethy D.R., Greenblatt D.J., Divoll M., Arendt R., Ochs H., Shader R.I. Impairment of diazepam metabolism by low-dose estrogen-containing oral contraceptive steroids. New England Journal of Medicine. 306:1982;791-792.
2. Abernethy D.R., Greenblatt D.J., Shader R.I. Imipramine disposition in users of oral contraceptive steroids. Clinical Pharmacology and Therapeutics. 35:1984;792-797.
3. Chouinard G., Ross-Chouinard A., Annable L. Extrapyramidal Symptom Rating Scale (ESRS). Canadian Journal of Neurological Science. 7:1980;233-243.
4. Domecq C., Naranjo C.A., Ruiz I., Busto U. Sex-related variations in the frequency and characteristics of adverse drug reactions. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 18:1980;362-366.
5. Gaw, A., 1992. Psychiatric care of Chinese Americans. In: Gaw, A. (Ed.), Culture, Ethnicity and Mental Illness. American Psychiatric Press, Washington, DC, pp. 245-280.
6. Jann, M.W., Lam, Y.W.F., Chang, W.H., 1993. Haloperidol and reduced haloperidol concentrations in different ethnic populations and interindividual variabilities in haloperidol metabolism. In: Lin, K.M., Poland, R.E., Nakasaki, G. (Eds.), Psychopharmacology and Psychobiology of Ethnicity. American Psychiatric Press, Washington, DC, pp. 133-152.
7. 2 receptor occupancy with low-dose haloperidol treatment: a PET study. American Journal of Psychiatry. 153(7):1996;948-950.
8. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-1176.
9. Kimmel S., Gonsalves L., Youngs D., Gidwani G. Fluctuating levels of antidepressants premenstrually. Journal of Psychosomatic Obstetrics and Gynecology. 13:1992;277-280.
10. Lin K.M., Finder E. Neuroleptic dosage for Asians. American Journal of Psychiatry. 140:1983;490-491.
11. Lin K.M., Poland R.E., Nuccio I. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. American Journal of Psychiatry. 146(10):1989;1307-1311.
12. Makkar R.R., Fromm G.S., Steinman R.T., Meissner M.D., Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Journal of the American Medical Association. 270:1993;2590-2597.
13. McEvoy J.P., Hogarty G.E., Steingard S. Optimal dose of neuroleptic in acute schizophrenia. Archives of General Psychiatry. 48:1991;739-745.
14. McGuffin P., Farmer A., Harvey I.A. Polydiagnostic application of operational criteria in studies of psychotic illness. Archives of General Psychiatry. 48:1991;764-770.
15. öm et al., 1993
16. 2-dopamine receptor occupancy in relation to antipsychotic drug effects - a double-blind PET study of schizophrenic patients. Biological Psychiatry. 33:1993;227-235.
17. Pollock B.G. Recent developments in drug metabolism of relevance to psychiatrists. Harvard Review of Psychiatry. 2:1994;204-213.
18. Pollock B.G. The endocrine-treatment interface: gender differences in psychotropic drug metabolism. Psychopharmacology Bulletin. 33(2):1997;235-241.
19. Potkin S.G., Shen Y., Pardes H., Phelps B.H., Zhou D., Shu L., Korp E., Wyatt R.J. Haloperidol concentration in Chinese patients. Psychiatry Research. 12:1984;167-172.
20. Rubin R.T. Serum haloperidol determinations in psychiatric patients: comparison of methods and correlation with serum prolactin. Archives of General Psychiatry. 37:1980;1069-1074.
21. Özdemir, 1997
22. Shulman R.W., Özdemir V. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly. Canadian Journal of Psychiatry. 42(suppl 1):1997;4S-9S.
23. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1990. User's Guide for the Structured Clinical Interview for DSM-III-R: SCID. American Psychiatric Press, Inc., Washington, DC.
24. Yamamoto, J., Lin, K.M., 1995. Psychopharmacology, ethnicity and culture. In: Oldham, J., Michelle, B.R.R. (Eds.), Review of Psychiatry, Vol. 14. American Psychiatric Press, Washington, DC, pp. 529-541.